Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA
Rank in Stocks
#15407
Drugs Made In America Acquisition Corp. does not have significant operations.... Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Share Price
$10.89
Last synced: 2026-11-09
Market Cap
$264.38M
Change (1 day)
0.00%
Change (1 year)
5.52%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Category
Financial Services
EPS for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
EPS as of June 2026 TTM: $0.20
According to Drugs Made In America Acquisition Corp. Ordinary Shares's latest financial reports, its current EPS (TTM) is $0.20. At the end of 2025 the company had an EPS of $0.19, an increase over its 2024 EPS of $-0.06.
EPS history for Drugs Made In America Acquisition Corp. Ordinary Shares from 2024 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.20 | 5.26% |
| 2025 | $0.19 | -439.29% |
| 2024 | $-0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $0.00 | -99.50% |
US
|
|
| $0.38 | 90.00% |
US
|
|
| $0.00 | -101.25% |
CN
|
|
| $0.09 | -57.50% |
US
|
|
| $-4.91 | -2,555.00% |
US
|
Questions about Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS)
What is Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS)?
Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS) over the last twelve months is $0.20, as of Jun 2026.
What was Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS) in 2025?
In 2025, Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS) was $0.19, compared with $-0.06 in 2024.
How does Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS) compare with similar companies?
Drugs Made In America Acquisition Corp. Ordinary Shares's earnings per share (EPS) ($0.20) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Worldwide Webb Acquisition Corp., with $0.38.